Abstract
We have investigated the effect of the immunomodulator ubenimex (bestatin) on tumor cell invasion of reconstituted basement membrane (Matrigel). The invasion of B16‐BL6 melanoma cells and Lewis lung carcinoma (3LL) cells into Matrigel‐coated filters was inhibited by the presence of bestatin in a concentration‐dependent manner. The prctrcatment of either tumor cells or Matrigel with bestatin, however, had little effect on the invasion of tumor cells. Since bestatin was found to inhibit aminopeptidase in addition to its immunomodulating activities, the inhibition of tumor invasion by bestatin is likely to be associated with the action as an enzyme inhibitor. Other aminopeptidase inhibitors, arphamcnine B and amastatin A, could also inhibit tumor cell invasion into Matrigel. Bestatin inhibited hydrolyzing activities towards substrates of aminopeptidases in B16‐BL6 melanoma cells. However, bestatin did not have any effect on the haptotactic migration and adhesion of tumor cells to the substrates. These results indicated that bestatin may inhibit tumor cell invasion through a mechanism involving its inhibitory action on aminopeptidases in tumor cells.
Keywords: Ubenimex (Bestatin), Tumor metastasis, Invasion, Haptotactic migration, Adhesion
Full Text
The Full Text of this article is available as a PDF (395.5 KB).
REFERENCES
- 1. ) Liotta , L. A. , Rao , C. V.Barsky , S. H.Tumor invasion and the extracellular matrix . Lab. Invest , 49 , 636 – 649 ( 1983. ). [PubMed] [Google Scholar]
- 2. ) Strauli , P. and Haemmerli , G.The role of cell motility in invasion . Cancer Metastasis Rev. , 3 , 127 – 141 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 3. ) McCarthy , J. B. , Basara , M. L. , Palm , S. L. , Sas , D. F. and Furcht , L. T.The role of cell adhesion proteins—laminin and fibronectin—in the movement of malignant and metastatic cells . Cancer Metastasis Rev. , 4 , 125 – 152 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Nicolson , G. L.Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression . Cancer Res. , 47 , 1473 – 1487 ( 1987. ). [PubMed] [Google Scholar]
- 5. ) McCarthy , J. B. and Furcht , L. T.Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro . J. Cell Biol. , 98 , 1474 – 1480 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. ) Verani , J.Chemotaxis of metastatic tumor cells . Cancer Metastasis Rev. , 1 , 17 – 28 ( 1982. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Fidler , I. J.Gersten , D. M. and Hart , I. R.The biology of cancer invasion and metastases . Adv. Cancer Res. , 28 , 149 – 250 ( 1978. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Umezawa , H. , Aoyagi , T. , Suda , H. , Hamada , M. and Takeuchi , T.Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes . J. Antibiot. , 29 , 97 – 99 ( 1976. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Suda , H. , Aoyagi , T. , Takeuchi , T. and Umezawa , H.Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomers . Arch. Biochem. Biophys. , 177 , 196 – 200 ( 1976. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Leyhausen , G. , Schuster , D. K.Vaith , P. , Zahn , R. K.Umezawa , H. , Falke , D. and Mïiller , W. E. G.Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin . Biochem. Pharmacol. , 32 , 1051 – 1057 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Kuramochi , H. , Motegi , A. , Iwabuchi , M. , Takahashi , K. , Horinishi , H. and Umezawa , H.Action of ubenimex on aminopeptidase activities in spleen cells and peritoneal macrophages from mice . J. Antibiot. , 40 , 1605 – 1611 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Abe , F. , Shibuya , K. , Uchida , M. , Takahashi , K. , Horinishi , H. , Matsuda , A. , Ishizuka , M. , Takeuchi , T. and Umezawa , H.Effect of bestatin on syngeneic tumors in mice . Gann , 75 , 89 – 94 ( 1984. ). [PubMed] [Google Scholar]
- 13. ) Schlorlemmer , H‐U. , Bosslet , K. , Dickneite , G. , Luben , G. and Sedlacek , H. H.Studies on the mechanisms of action of the immunomodulator bestatin in various screening test systems . Behring Inst. Mitt. , 74 , 157 – 173 ( 1984. ). [PubMed] [Google Scholar]
- 14. ) Ishizuka , M. , Masuda , T. , Kanbayashi , N. , Fukusawa , S. , Takeuchi , T. , Aoyagi , T. and Umezawa , H.Effect of bestatin on mouse immune system and experimental murine tumors . J. Antibiot. , 33 , 642 – 652 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Miwa , H. , Oka , T. , Tsurumi , T. , Sakae , Y. and Orita , K.Experimental and clinical studies of bestatin as an immunomodulator . Jpn. J. Cancer Chemother. , 9 , 1019 – 1024 ( 1982. ). [PubMed] [Google Scholar]
- 16. ) Ikeda , S. , Miyasato , H. , Saito , K. , Nakayama , H. and Tajima , K.Phase I study of bestatin, (II) clinical trial of bestatin in malignant skin tumors . In “ Small Molecular Immunomodifiers of Microbial Origin,” ed. Umezawa H. , pp. 143 – 158 ( 1981. ). Pergamon Press; , New York ). [Google Scholar]
- 17. ) Majima , H.Phase I and preliminary phase II clinical trials of bestatin . In “ Small Molecular Immunomodifiers of Microbial Origin ,“ ed. Umezawa H. , pp. 173 – 178 ( 1981. ). Pergamon Press; , New York ). [Google Scholar]
- 18. ) Bruley‐Rosset , M. , Florentin , I. , Kiger , N. , Schulz , J. and Mathe , G.Restoration of impaired immune functions of aged animals by chronic bestatin treatment . Immunology , 38 , 75 – 83 ( 1979. ). [PMC free article] [PubMed] [Google Scholar]
- 19. ) Saito , K. , Takegoshi , K. , Aoyagi , T. , Umezawa , H. and Nagai , Y.Stimulatory effect of bestatin, a new specific inhibitor of aminopeptidase, on the blastogenesis of guinea pig lymphocytes . Cell. Immunol. , 40 , 247 – 262 ( 1978. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Schorlemmer , H. U. , Bosslet , K. and Sedlacek , H. H.The ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes . Cancer Res. , 43 , 4148 – 4153 ( 1983. ). [PubMed] [Google Scholar]
- 21. ) Dunlap , B. E. , Dunlap , S. A. and Rich , D. H.Effect of bestatin on in vitro responses of murine lymphocytes to T‐cell stimuli . Scand. J. Immunol. , 20 , 237 – 245 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 22. ) Talmadge , J. E. , Lenz , B. F. , Pennington , R. , Long , C. , Phillips , H. , Schneider , M. and Tribble , H.Immunomodulatory and therapeutic properties of bestatin in mice . Cancer Res. , 46 , 4505 – 4510 ( 1986. ). [PubMed] [Google Scholar]
- 23. ) Albini , A. , Iwamoto , Y. , Kleinman , H. K. , Martin , G. R. , Aaronson , S. A.Kozlowski , J. M. and McEwan , R. N.A rapid in vitro assay for quantitating the invasive potential of tumor cells . Cancer Res. , 47 , 3239 – 3245 ( 1987. ). [PubMed] [Google Scholar]
- 24. ) Koyama , M.Pharmacokmetics and biotransformation of bestatin . In “ Recent Results on Bestatin ,“ ed. Umezawa H. , pp. 41 – 50 ( 1986. ). Japan Antibiotics Res. Assoc. , Tokyo ). [Google Scholar]
- 25. ) Talmadge , J. E. , Koyama , M. , Matsuda , A. , Long , C. and Abe , F.Immunotherapeutic properties of bestatin, mechanism of activity . In “ Recent Results on Bestatin ,“ ed. Umezawa H. , pp. 8 – 25 ( 1986. ). Japan Antibiotics Res. Assoc. , Tokyo ). [Google Scholar]
- 26. ) Morahan , P. S. , Edelson , P. J. and Gass , K.Changes in macrophages ectoenzymes associated with antitumor activity . J. Immunol. , 125 , 1312 – 1317 ( 1980. ). [PubMed] [Google Scholar]
- 27. ) Wachsmuth , E. D.Aminopeptidase as a marker for macrophage differentiation . Exp. Cell Res. , 96 , 409 – 412 ( 1975. ). [DOI] [PubMed] [Google Scholar]
- 28. ) Poole , A. R. , Tutman , K. J. , Recklies , A. D. and Stoker , T. A.Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas . Nature , 273 , 545 – 547 ( 1978. ). [DOI] [PubMed] [Google Scholar]
- 29. ) Recklies , A. D. , Mort , J. S. and Poole , A. R.Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization . Cancer Res. , 42 , 1026 – 1032 ( 1982. ). [PubMed] [Google Scholar]
- 30. ) Sloane , B. F. , Honn , K. V. , Sadler , J. C. , Turner , W. A. , Kimpson , J. J. and Taylor , J. D.Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential . Cancer Res. , 42 , 980 – 986 ( 1982. ). [PubMed] [Google Scholar]
- 31. ) Robertson , D. M. and Williams , D. C.In vitro evidence for neutral collagenase activity in an invasive mammalian tumor . Nature , 221 , 259 – 260 ( 1969. ). [DOI] [PubMed] [Google Scholar]
- 32. ) Hashimoto , K. , Yamanishi , Y. , Maeyens , E. , Dabbous , M. K. and Kanzaki , T.Collagenolytic activities of squamous cell carcinoma of the skin . Cancer Res. , 33 , 2790 – 2801 ( 1973. ). [PubMed] [Google Scholar]
- 33. ) Liotta , L. A. , Tryggvason , K. , Garbisa , S. , Hart , I. , Foltz , C. M. and Shafie , S.Metastatic potential correlates with enzymatic degradation of besement membrane collagen . Nature , 284 , 67 – 68 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 34. ) Eisenbach , L. , Segal , S. and Feldman , M.Proteolytic enzymes in tumor matastasis. II. Collagenase type IV activity in subcellular fractions of cloned tumor cell populations . J. Natl. Cancer Inst. , 74 , 87 – 93 ( 1985. ). [PubMed] [Google Scholar]
- 35. ) Dano , K. , Andreasen , P. A. , Grondahl‐Hansen , J. , Kristensen , P. , Nielsen , L. S. and Skriver , L.Plasminogen activators, tissue degradation and cancer . Adv. Cancer Res. , 44 , 139 – 266 ( 1985. ). [DOI] [PubMed] [Google Scholar]